ACQUISITION OF NON-CATALOGED MEDICINES GROUP A1 (ALIMENTARY TRACT AND METABOLISM) FIRST QUARTER - 2025 PROGRAMMING.- PHARMACY AND THERAPEUTICS COMMITTEE MINUTES 002 – 2025

This tender concerns the acquisition of non-cataloged medicines specifically within Group A1, focusing on the Alimentary Tract and Metabolism therapeutic area, for the first quarter of the 2025 programming year. The procurement process is being managed by the CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA "MARIA ROSA PARRA ARREAGA" CCQA-HD SAMBORONDON, identified by process code SIE-CCQAHDSAMBORONDON-2025-0023-1241290. The contracting modality is Electronic Reverse Auction, a method designed to achieve competitive pricing through an online bidding process. The specific item required is Nystatin, presented as an oral liquid solution at a concentration of 100,000 IU/mL. The packaging specification is a box containing one 60 mL bottle (minimum) with a dispenser. The total quantity required is 500 units, with an estimated value of USD 454,030.20. This tender is a crucial part of the hospital's pharmaceutical supply chain management for the upcoming year, ensuring the availability of essential medications for patient treatment within the specified therapeutic group. The Pharmacy and Therapeutics Committee's minutes (002-2025) indicate the formal approval and necessity of this acquisition.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 454,030.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.